Using Human Bone Marrow Stem Cells to Treat Diabetes in Mice
Author Information
Author(s): Zhao Min, Amiel Stephanie A., Ajami Sanaz, Jiang Jie, Rela Mohamed, Heaton Nigel, Huang Guo Cai
Primary Institution: King's College London School of Medicine
Hypothesis
Can human marrow stromal cells be differentiated into insulin-producing cells to treat diabetes?
Conclusion
The study shows that human marrow stromal cells can be induced to produce insulin and reduce blood glucose levels in diabetic mice.
Supporting Evidence
- 12.5% of the grafted cells expressed insulin after transplantation.
- 13 out of 16 mice became normoglycaemic after receiving the cells.
- Insulin mRNA was detected in the kidneys of transplanted mice.
Takeaway
Scientists used special cells from human bone marrow to help mice with diabetes make insulin and lower their blood sugar.
Methodology
Human marrow stromal cells were genetically modified and transplanted into diabetic mice to assess their ability to produce insulin.
Limitations
The study used cell lines rather than primary cells, which may limit clinical applicability.
Participant Demographics
Male SCID mice were used as recipients for the transplanted cells.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website